UV spectrophotometric test for analysis of antihypertensive drug combinations containing amlodipine
1 Bulgarian Drug Agency, Str. “Damyan Gruev” 8, Sofia 1303, Bulgaria.
2 Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University-Sofia, Str. “Dunav” 2, Sofia 1000, Bulgaria.
3 Department of Health Policy and Management, Faculty of Public Health, Medical University-Sofia, Str. “White Sea” 8, Sofia, Bulgaria.
Research Article
World Journal of Advanced Pharmaceutical and Life Sciences, 2022, 02(01), 001–008.
Article DOI: 10.53346/wjapls.2022.2.1.0036
Publication history:
Received on 02 December 2021; revised on 01 March 2022; accepted on 03 March 2022
Abstract:
The present study provides rapid test for the identity and quantification of Amlodipine besylate as monoproduct and in double and triple antihypertensive drug combinations. Test represents direct analysis - drug mixtures are analyzed in solution without prior separation using UV-VIS spectrophotometry. The spectral characteristics of the complex spectrum are used for authentication, counterfeiting, identification and assay. Basic spectral characteristics are determined and analytical parameters of the validation process are investigated. The method uses 4 types of calculations for normal and derivative spectrophotometry at different analytical zones and fixed wavelengths in the range 190 - 500 nm. For double mixtures Amlodipine / Valsartan, the best results are obtained by determining at the 1st derivative of the function, the 2nd polynomial level, the presence of 3 smoothing points, the analytical range is 190 - 400 nm, and the fixed lengths of the waves - 266 and 360 nm. For triple mixtures containing Amlodipine / Valsartan / Hydrochlorothiazide, the best results are obtained with IVth calculation type for Amlodipine and Valsartan and Ist, IIIrd and IVth for Hydrochlorothiazide. The developed method was compared with available in European Pharmacopoeia and US Pharmacopoeia methods for assay of Amlodipine substance and tablets respectively. The results show comparability and meet the pharmacopoeia criteria.
Keywords:
Amlodipine besylate; Antihypertensive drug combination; UV-spectrophotometry; Validation
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0